Corcept Therapeutics Incorporated logo
Corcept Therapeutics Incorporated CORT
€ 34.37 2.78%

Quartalsbericht 2025-Q3
hinzugefügt 04.11.2025

report update icon

Corcept Therapeutics Incorporated Langfristiger Schuldenstrom 2011-2026 | CORT

Langfristiger Schuldenstrom Jährlich Corcept Therapeutics Incorporated

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
829 K 151 K 1.14 M 526 K 2.05 M 1.56 M - - 14.7 M 15 M 9.42 M 5.74 M 2.65 M -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
15 M 151 K 4.88 M

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Adaptive Biotechnologies Corporation Adaptive Biotechnologies Corporation
ADPT
10.2 M $ 18.38 -0.68 % $ 2.7 B usaUSA
Amgen Amgen
AMGN
107 M $ 344.65 0.81 % $ 185 B usaUSA
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals
ARWR
7.29 M $ 71.99 3.84 % $ 9.63 B usaUSA
Biogen Biogen
BIIB
86.4 M $ 178.18 -0.95 % $ 25.9 B usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.65 1.92 % $ 16.6 M usaUSA
Adagene Adagene
ADAG
1.18 M $ 2.96 7.64 % $ 167 M chinaChina
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 4.16 3.74 % $ 9.05 B israelIsrael
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.18 0.32 % $ 7.65 B australiaAustralia
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
768 K $ 1.86 1.1 % $ 167 M israelIsrael
Aptose Biosciences Aptose Biosciences
APTO
428 K - -45.71 % $ 1.2 M canadaCanada
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
Celldex Therapeutics Celldex Therapeutics
CLDX
1.45 M $ 24.86 1.06 % $ 1.6 M usaUSA
Cellectis S.A. Cellectis S.A.
CLLS
8.38 M $ 3.87 2.22 % $ 116 M franceFrance
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
4.49 M $ 1.41 - $ 264 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
14.2 M $ 224.87 -0.54 % $ 5 B danmarkDanmark
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
BioNTech SE BioNTech SE
BNTX
39.5 M $ 110.01 -3.29 % $ 27.2 B germanyGermany
Athira Pharma Athira Pharma
ATHA
414 K - - $ 269 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
5.05 M $ 1.39 1.5 % $ 355 M britainBritain
AgeX Therapeutics AgeX Therapeutics
AGE
428 K - -10.17 % $ 12.2 K usaUSA
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
710 K $ 1.73 -1.43 % $ 82.4 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
5.38 M - -15.15 % $ 60.3 M britainBritain
DBV Technologies S.A. DBV Technologies S.A.
DBVT
654 K $ 21.75 0.65 % $ 2.11 B franceFrance
Brickell Biotech Brickell Biotech
BBI
49 K - -5.38 % $ 6.06 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
224 M $ 14.25 4.13 % $ 4.4 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
410 K - 1.93 % $ 17.4 M usaUSA
Atreca Atreca
BCEL
3.54 M - -11.76 % $ 5.79 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
937 K $ 6.72 2.05 % $ 1.39 B usaUSA